Lifecore to file for non-stick gel approval:
This article was originally published in Clinica
Executive Summary
Lifecore Biomedical is to seek US approval next June for its Intergel solution for preventing post-operative adhesions. The company has completed a 200-patient trial of the ferric hyaluronate gel in female patients who have undergone open abdominal surgery. Additional cases will be treated pending FDA permission to close the study. Further studies are under way in patients who have undergone minimally invasive surgery.